A biopharma and vaccine stronghold in the EU core. Compare EU-GMP Belgian CDMOs across biologics, vaccines, and drug product — by capability and site.
52 companies listed
Belgium hosts a remarkably dense biopharmaceutical sector for its size, with deep biologics and vaccine expertise and one of the highest concentrations of clinical and manufacturing activity per capita in Europe. Its CDMO base centers on biologics, vaccines, and drug product, supported by clusters around Wallonia's BioPark and Flanders.
Belgian facilities operate under EU GMP, recognized across the EU and frequently accepted by the FDA via mutual recognition agreements. The country's central location, multilingual workforce, and excellent logistics make it a natural EU manufacturing and distribution hub.
For biologics and vaccine programs seeking EU regulatory standing and a mature bioprocess ecosystem in the heart of the continent, Belgium offers specialist capacity that belies its small geographic footprint.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Our AI Matchmaker analyzes your project requirements and matches you with qualified Belgium manufacturing partners. Free for buyers.